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o r i g i n a l a r t i c l e
Evaluation of the Effectiveness of Common Hospital Hand
Disinfectants Against Methicillin-Resistant Staphylococcus aureus,
Glycopeptide-Intermediate S. aureus, and Heterogeneous
Glycopeptide-Intermediate S. aureus
Mandy Wootton, PhD; Timothy R. Walsh, PhD; Eleri M. Davies, MRCPath; Robin A. Howe, MRCPath
background. The presence of methicillin-resistant Staphylococcus aureus (MRSA) and glycopeptide-intermediate S. aureus (GISA) in
hospitals poses a significant challenge to hospital infection control teams. The use of disinfectants for both surface and hand cleaning is
an essential part of the infection control measures.
objective. To evaluate the effectiveness of common hospital hand disinfectants against MRSA, GISA, and heterogeneous GISA (hGISA).
methods. For methicillin-susceptible S. aureus (MSSA), MRSA, GISA, and hGISA, the levels of susceptibility to hand disinfectants and
their active ingredients were determined. Suspension tests were performed on commercial handwashing products.
results. Minimum inhibitory concentrations (MICs) of 2-propanol, chlorhexidine, and hexachlorophene were similar for all phenotypes.
The MICs of cetrimide and triclosan were higher for the MRSA, GISA, and hGISA strains than for the MSSA strain. The MICs for the
chlorhexidine-containing agents Hibisol and Hibiscrub (AstraZeneca) and for the propanol-containing agent Sterillium (Medline) were 1–
2-fold lower for the MSSA strains than for the MRSA, GISA, and hGISA strains. Suspension tests showed that the GISA and hGISA strains
were less susceptible to the triclosan-containing agent Aquasept (SSL) than were the MRSA and MSSA strains, with resistance increasing
with glycopeptide resistance. Products containing Betadine (Purdue) were more effective against the GISA and hGISA strains than against
the MRSA and MSSA strains, especially after the strain was exposed to the product for 30 seconds.
conclusions. Using the EN 1040 standard criteria for the performance of disinfectants, we determined that all agents, except 50%
Aquasept for hGISA and 0.33% hexachlorophene for GISA, performed effectively. However, the GISA and hGISA strains were less susceptible
to triclosan-containing products, compared with the MRSA stains, but were more susceptible to products containing Betadine.
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Staphylococcus aureus—in particular, methicillin-resistant S.
aureus (MRSA)—is a major cause of hospital-acquired in-
fection. Strains of methicillin-susceptible S. aureus (MSSA)
are generally susceptible to commonly used hospital disin-
fectants; however, some MRSA strains have been reported to
have reduced susceptibility to chlorhexidine, quaternary am-
monium compounds (QACs), cetrimide, and benzalkonium
chloride.1-4 For MRSA, a number of genes (qacA–D and
norA), some carried by plasmids, have been shown to be
resistant to chlorhexidine, diamidines, and QACs.5-8 The pres-
ence of qac genes is common among MRSA strains and co-
agulase-negative staphylococci; these genes mediate the ef-
flux-based resistance to QACs.9 These genes have also been
found in a strain of vancomycin-resistant S. aureus isolat-
ed in the United States.10 Further reports have shown a ge-
netic linkage between these genes and the antibiotic resis-
tance genes blaZ, aacA–aphD, dfrA, and ble on the same plas-
mids, and concern about the transfer of these genes is
understandable.11-13
Alternatively, intrinsic resistance to biocides can be con-
ferred by cell-wall thickness and by characteristics associated
with biofilm production, such as slow growth rate and altered
cell-wall composition.14 Reduced cellular permeability and
components of the cell wall may limit the concentration of
active biocides that reach the target site(s).15 For Bacillus me-
gaterium, a thickened and altered peptidoglycan component
of the cell walls has demonstrated reduced susceptibility to
disinfectants and antiseptics.16 The cell walls of staphylococci
are composed of peptidoglycan and teichoic acid and are not
normally an effective barrier against disinfectants or antisep-
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table 1. Mean Minimum Inhibitory Concentrations (MICs; mg/L) of Agents Used in Hand Disinfectants, With
Levels of Susceptibility of 6 Phenotypes of Staphylococcus aureus
Phenotype, MIC 1-propanol 2-propanol Chlorhexidine Triclosan Cetrimide Hexachlorophene
MSSA ( )np 10
MIC range 128 32 0.008–0.015 0.015–2 2–4 0.25–0.5
MIC50 128 32 0.008 0.015 2 0.5
MIC90 128 32 0.015 0.5 2 0.5
EMRSA-15 ( )np 10
MIC range 128 32 0.015 0.015–0.03 8–16 0.25–0.5
MIC50 128 32 0.015 0.03 8 0.5
MIC90 128 32 0.015 0.03 8 0.5
EMRSA-16 ( )np 10
MIC range 128 32 0.015 0.015 2–32 0.25–1
MIC50 128 32 0.015 0.015 16 0.5
MIC90 128 32 0.015 0.015 16 0.5
MRSA ( )np 16
MIC range 64–128 32–64 0.008–0.06 0.015–4 2–16 0.25–1
MIC50 128 32 0.015 0.03 8 0.5
MIC90 128 64 0.03 2 8 0.5
hGISA ( )np 45
MIC range 16–128 32–64 0.008–0.03 0.015–2 4–32 0.12–0.5
MIC50 32 32 0.03 1 16 0.25
MIC90 32 32 0.03 2 16 0.5
GISA ( )np 8
MIC range 16–32 32–64 0.008–0.03 0.015–4 2–16 0.25–0.5
MIC50 32 32 0.015 0.015 8 0.25
MIC90 32 64 0.015 2 16 0.5
note. The MIC50 and MIC90 values are the MICs required to inhibit 50% and 90% of the organisms, respectively. EMRSA-
15, epidemic strain of type 15 methicillin-resistant S. aureus (MRSA); EMRSA-16, epidemic strain of type 16 MRSA; GISA,
glycopeptide-intermediate S. aureus; hGISA, heterogeneous GISA; MSSA, methicillin-susceptible S. aureus.
tics.17 For clinical strains of S. aureus with intermediate re-
sistance to glycopeptide (hereafter referred to as glycopeptide-
intermediate S. aureus [GISA]) or with heterogeneous GISA
(hereafter referred to as hGISA), the cell wall is grossly thick-
ened with altered cross-linking, and it is possible that these
alterations in the cell wall may affect susceptibility to
disinfectants.
The emergence of GISA strains and the more abundant
hGISA strains is likely to pose a major challenge to hospital
infection control teams; with enhanced infection control mea-
sures already in operation in many hospitals, the need for
accurate data on the efficacy of disinfectant agents against
these strains is paramount. A cornerstone of these infection
control measures will be effective hand disinfection to prevent
the spread of infection from patient to patient, either by
healthcare workers or visiting persons. In our study, we eval-
uated the effectiveness of the cleaning agents used in hand
disinfectants and of commercially available hand disinfection
products against a range of S. aureus strains with differing
levels of susceptibility to methicillin and glycopeptide. Min-
imum inhibitory concentrations (MICs) of cleaning agents
were determined, and suspension tests were employed to
mimic the use of hand disinfectants.
methods
MICs of Cleaning Agents
The MICs were determined for the following cleaning agents,
by the use of the Clinical Laboratory Standards Institute rec-
ommended methods and Mueller-Hinton agar plates with log
2 dilutions (from 0.008 to 128 mg/L): povidone-iodine (a
halogen-releasing agent), triclosan (a bisphenol compound),
cetrimide (a QAC), hexachlorophene (a bisphenol com-
pound), 1-propanol (an alcohol), 2-propanol (an alcohol),
and chlorhexidine (a biguanidine derivative). Also tested were
the following commercial hand disinfectant products, which
were also placed in Mueller-Hinton agar with log 2 dilutions:
Hibisol (2.5% chlorhexidine gluconate) and Hibiscrub (20%
chlorhexidine gluconate) from AstraZeneca; Sterillium (45%
2-propanol, 30% 1-propanol, and 0.2% mecetronium etil-
sulphate) from Medline; Aquasept (2% triclosan, diluted to
give a range of 0.0015%–0.08%) and Manusept (0.5% tri-
closan, diluted to give a range of 0.0006%–0.6%) from SSL;
and Betadine skin cleanser (4% povidone-iodine), Betadine
aqueous solution (10% povidone-iodine), and Betadine al-
coholic solution (10% povidone-iodine in alcohol) from
Purdue.18
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table 2. Mean Minimum Inhibitory Concentrations (MICs; mg/L) of Commercially Available Hand Disinfectants, With Levels of
Susceptibility of 4 Phenotypes of Staphylococcus aureus
Phenotype,
MIC Hibisol Hibiscrub Sterillium Aquasept Manusept
Betadine
Skin
cleanser
Aqueous
solution
Alcoholic
solution
MSSA ( )np 10
MIC range 0.03 0.0015 0.015–0.06 0.0012 to 10.6 0.0012 to 10.08 0.12–0.5 2.5 2.5
MIC50 0.03 0.0015 0.015 0.0012 0.0025 0.5 2.5 2.5
MIC90 0.03 0.0015 0.03 10.6 10.08 0.5 2.5 2.5
MRSA ( )np 10
MIC range 0.03–0.06 0.003 0.03–0.25 0.0012 0.0012–0.005 0.03–0.5 2.5 2.5
MIC50 0.06 0.003 0.12 0.0012 0.0025 0.06 2.5 2.5
MIC90 0.06 0.003 0.12 0.0012 0.005 0.5 2.5 2.5
hGISA ( )np 11
MIC range 0.03–0.12 0.0015–0.006 0.03–0.25 0.0012–0.3 0.0025 to 10.08 0.03–0.5 2.5–5 2.5
MIC50 0.06 0.003 0.12 0.0012 0.0025 0.5 2.5 2.5
MIC90 0.06 0.003 0.25 0.3 10.08 0.5 2.5 2.5
GISA ( )np 10
MIC range 0.03–0.06 0.0015–0.006 0.03–0.25 0.0012–0.3 0.0025 to 10.08 0.03–0.5 2.5 2.5
MIC50 0.03 0.0015 0.12 0.0012 0.0025 0.5 2.5 2.5
MIC90 0.06 0.003 0.25 0.3 0.08 0.5 2.5 2.5
note. The MIC50 and MIC90 values are the MICs required to inhibit 50% and 90% of the organisms, respectively; the MICs of these commerically
available hand disinfectants were placed on Mueller-Hinton agar plates with log 2 dilutions. GISA, glycopeptide-intermediate S. aureus; hGISA, hetero-
geneous GISA; MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus.
The strains tested were 10 strains of MSSA, 10 epidemic
strains of type 15 MRSA, 10 epidemic strains of type 16
MRSA, 16 strains of MRSA, 45 strains of hGISA, and 8 strains
of GISA (plus the control S. aureus strain ATCC 6538). Two
sets of related hGISA and GISA strains were included in the
strain sets used: LIM1 (hGISA) and LIM2 and LIM3 (GISA);
and PC1 (hGISA) and PC2 (GISA).
Suspension Tests
Suspension tests were performed with agent concentrations
(ie, at 100% concentraton and/or at 50% concentration but
diluted with water) and recorded times (ie, for handwashing
duration) in a way that mimicked the actual use of hand
disinfectants. Suspension tests were performed, according to
the Council of Europe and the European standard EN 1040,
on the commercial agents Hibiscrub (used at 10%), Hibisol
(used at 100% and 50%), Aquasept (used at 50%), Manusept
(used at 50%), Sterillium (used at 100% and 50%), Betadine
antiseptic solution (used at 100% and 50%), Betadine alco-
holic solution (used at 100% and 50%), Betadine skin cleanser
(used at 100% and 50%), and 0.33% hexachlorophene (used
at a 10% concentration of the commercially available 3%
soap).19,20
The disinfectants were inactivated during suspension tests
by the use of one of the following neutralizing fluids:
1. 3 g lecithin (Sigma), 30 mL Tween 80 (Sigma), 5 g Na
thiosulphate (BDH), 10 mL phosphate buffer, and 1 g l-his-
tidine (Sigma) in 1 L of water (for Betadine alcoholic solution
and Betadine skin cleanser).
2. 3 g lecithin, 30 mL Tween 80, 5 g Na thiosulphate, 10
mL phosphate buffer, and 30 g saponine (Sigma) in 1 L of
water (for Aquasept, Manusept, and 0.33% hexachlorophene).
3. 30 mL Tween 80, 4 g sodium dodecyl sulfate, 3 g lecithin,
and 10 mL phosphate buffer in 1 L of water (for Hibiscrub,
Hibisol, and Sterillium).
Each disinfectant solution (ie, 8 mL) was mixed with 1 mL
of water of standard hardness (prepared by adding 3 mL of a
solution of 31.74 g magnesium chloride and 73.99 g calcium
chloride in 1 L of water to 4 mL of a solution of 56.03 g sodium
bicarbonate [BDH] in 1 L of water) and 1 mL of test bacterial
suspension (approximately organisms) (prepared by81.5# 10
adding 0.5 McFarland suspension from culture plates to dil-
uents of 1 g peptone [Sigma] or 8.5 g sodium chloride [BDH]
in 1 L water) and incubated for 30, 60, 120, and 600 seconds
at room temperature. Simultaneously, 1 mL of bacterial sus-
pension was added to 9 mL of water of standard hardness and
spread onto a tryptone soya agar plate for initial inoculum
calculations. These samples were removed and added to 1 mL
of water of standard hardness and 8 mL of neutralizing fluid
to inactivate disinfectant activity. After 5 minutes at room tem-
perature, 500 mL of the bacterial suspension samples were
spread onto duplicate tryptone soya agar plates, and these plates
were incubated in air at 37C for 24 hours. The surviving
bacteria were counted, and a cleaning agent was deemed to be
effective against the organism tested if the reduction in the
number of viable surviving colonies (ie, the log reduction fac-
tor) was at least 105 colony-forming units/mL within 5 minutes,
according to the criteria of European and British standards.
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table 3. Effectiveness of Commercial Handwashing Products
Against 4 Phenotypes of Staphylococcus aureus, Based on Log Re-
duction Factors (LRFs)
Agent, phenotype
LRF, by exposure time
30 sec 60 sec 120 sec 600 sec
Betadine aqueous 100%
MSSA 2.47 3.79 5.84 5.84
MRSA 2.1 3.46 5.82 5.82
hGISA 2.37 3.29 5.54 5.85
GISA 2.05 3.15 5.81 5.81
Betadine aqueous 50%
MSSA 1.28 3.04 5.99 6.06
MRSA 0.61 2.23 5.6 5.75
hGISA 2.15 3.83 5.7 5.7
GISA 1.95 4.26 5.64 5.69
Betadine alcohol 100%
MSSA 5.45 5.85 5.87 5.87
MRSA 5.42 5.7 5.83 5.83
hGISA 5.79 5.84 5.84 5.84
GISA 5.08 5.75 5.75 5.75
Betadine alcohol 50%
MSSA 1.74 1.92 5.89 5.89
MRSA 1.49 1.94 5.81 5.81
hGISA 2.71 3.56 5.67 5.91
GISA 1.47 1.82 4.64 5.78
Betadine skin cleanser 100%
MSSA 1.92 3.47 5.81 5.84
MRSA 2.74 4.64 5.75 5.75
hGISA 3.38 4.95 5.46 5.46
GISA 3.27 4.62 5.51 5.51
Betadine skin cleanser 50%
MSSA 1.55 2.21 5.9 5.9
MRSA 2.01 3.18 5.97 5.97
hGISA 1.57 2.67 5.66 5.86
GISA 1.15 2.31 5.75 5.91
Hibiscrub 10%
MSSA 5.39 5.88 5.91 5.91
MRSA 4.95 5.49 5.87 5.87
hGISA 5.05 5.71 5.75 5.75
GISA 4.91 5.98 5.99 5.99
Hibisol 100%
MSSA 5.87 5.87 5.87 5.87
MRSA 5.85 5.85 5.85 5.85
hGISA 5.93 5.93 5.93 5.93
GISA 5.87 5.87 5.87 5.87
Hibisol 50%
MSSA 5.99 6.02 6.02 6.02
MRSA 5.87 5.89 5.89 5.89
hGISA 5.91 5.91 5.91 5.91
GISA 5.78 5.84 5.84 5.84
Aquasept 50%
MSSA 3.95 4.14 5.34 5.88
MRSA 3.95 4.39 5.43 5.92
hGISA 2.68 3.19 3.61 4.47
GISA 3.7 3.96 4.95 5.87
Manusept 50%
MSSA 5.38 5.66 5.91 5.91
(continued)
table 3. (Continued)
Agent, phenotype
LRF, by exposure time
30 sec 60 sec 120 sec 600 sec
MRSA 5.27 5.86 5.86 5.86
hGISA 4.57 5.05 5.26 5.47
GISA 5.85 5.85 5.85 5.85
Sterillium 100%
MSSA 5.94 5.94 5.94 5.94
MRSA 5.72 5.72 5.72 5.72
hGISA 5.57 5.66 5.66 5.66
GISA 5.51 5.51 5.51 5.51
Sterillium 50%
MSSA 4.33 5.49 5.86 5.95
MRSA 4.9 5.79 5.97 5.97
hGISA 4.95 5.96 5.97 5.97
GISA 3.25 4.98 5.99 5.99
Hexachlorophene 0.33%
MSSA 2.28 2.46 4.46 5.92
MRSA 1.71 2.19 3.82 5.33
hGISA 2.13 2.69 3.75 5.53
GISA 2.23 2.56 3.71 4.99
note. GISA, glycopeptide-intermediate S. aureus; hGISA, heterogeneous
GISA; MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible
S. aureus.
Colony counts at 30 seconds were used to mimic the actual
time it takes to use a hand disinfectant. The recommendation
by the Healthcare Infection Control Practices Advisory Com-
mittee for duration of hand washing is currently 15 seconds;
however, a time of 30 seconds was selected as the minimum
time tested efficiently in vitro.
results
MICs of Cleaning Agents
The MICs of the cleaning agents used in hand disinfectants
are shown in Table 1. The MICs of 2-propanol, chlorhexidine,
and hexachlorophene were similar for all phenotypes. In con-
trast, the MIC50 and MIC90 values of 1-propanol for GISA
and hGISA were 2-fold lower than those for MRSA and
MSSA, which suggests that GISA and hGISA are more sus-
ceptible to 1-propanol. In contrast, the susceptibility to the
hand disinfectant Sterillium containing 45% 2-propanol, 30%
1-propanol, and 0.2% mecetronium etilsulphate was similar
for MRSA, GISA, and hGISA but lower for MSSA.
For MRSA, GISA, and hGISA, the cetrimide and triclosan
MIC50 values were 2–4-fold higher than those for MSSA, and
the cetrimide and triclosan MIC90 values were 2–8-fold higher
than those for MSSA. The levels of susceptibility to com-
mercially available hand disinfectants were similar for all
strains, regardless of the vancomycin resistance phenotype
(Table 2). However, the MICs of the chlorhexidine-containing
agents Hibisol and Hibiscrub and the propanol-containing
Sterillium were 1–2-fold lower for MSSA than for MRSA,
GISA, and hGISA.
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table 4. Mean Log Reduction Factors Used to Determine the Effectiveness of 9 Commercial Handwashing Products (After 30 Seconds
of Exposure) Against 4 Phenotypes of Staphylococcus aureus
Phenotypes
Betadine
aqueous
Betadine
alcohol
Betadine
skin Hibiscrub Hibisol Aquasept Manusept Sterillium Hexachlorophene
MSSA and MRSA 1.62 3.53 2.06 5.17 5.93 3.95 5.33 4.62 1.99
hGISA and GISA 2.13 3.77 2.35 4.98 5.85 3.19 5.21 4.1 2.18
note. GISA, glycopeptide-intermediate S. aureus; hGISA, heterogeneous GISA; MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible
S. aureus.
figure. Efficacy of Aquasept, Manusept, and Sterillium against related strains of Staphylococcus aureus with intermediate resistance to
glycopeptide and with heterogeneous intermediate resistance to glycopeptide. For the bacterial suspension tests, the surviving bacteria were
counted, and a cleaning agent was deemed to be effective against the organism tested if the reduction in the number of viable surviving
colonies (ie, the log reduction factor) was 105 colony-forming units (cfu)/mL or more within 5 minutes, according to the criteria of
European and British standards.
Suspension Tests
According to the EN 1040 standard criteria for the perfor-
mance of disinfectants, all cleaning agents, except 50% Aqua-
sept for hGISA and 0.33% hexachlorophene for GISA, were
effective, with log reduction factors of 5 or more at 600 sec-
onds (ie, at 10 minutes). With the use of Aquasept at 50%
strength, the hGISA strains had a mean log reduction factor
of 4.47 that was equivalent to a kill rate of 74.6% in 5 minutes.
This suggests that hGISA strains are slightly more resistant
to this agent than are the MRSA, MSSA, and GISA strains,
with log reduction factors of 100%, 100%, and 100%, re-
spectively. This correlates well with the higher MICs of tri-
closan found for hGISA (Tables 1 and 3). For GISA strains,
the log reduction factor achieved with 0.33% hexachloro-
phene was 4.99, which suggests a slight lowering of suscep-
tibility to this agent.
discussion
Concern has been steadily growing with regard to the po-
tential coresistance to antibiotics and disinfectants of clini-
cally important bacteria. The dominance of MRSA and the
emerging threat posed by GISA and hGISA in the clinical
setting heighten the importance of hand disinfection as an
infection control measure. The altered cell-wall physiology
seen in strains of GISA and hGISA, and their increased re-
sistance to glycopeptides, may be related to resistance to dis-
infectants; however, it is unlikely to be the sole factor.
In our study, the MICs of the hand disinfection agents 2-
propanol, chlorhexidine, and hexachlorophene were similar
for all phenotypes, which indicates that there are no signif-
icant differences between the levels of susceptibility for the
GISA, hGISA, MRSA, and MSSA strains. In contrast, the
levels of susceptibility to cetrimide were lower for the MRSA,
GISA, and hGISA strains than they were for the MSSA stains,
which confirms previous reports of reduced susceptibility to
QACs observed for MRSA, with MICs that were 1.5–3-fold
higher, compared with those for MSSA.21 For MRSA strains,
there is the possible presence of QAC resistance qac genes,
and, for QAC-resistant biofilm-associated cells, slow growth
rates were shown to be the predominant resistance factor.22
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All GISA and hGISA strains exhibited slower growth rates,
compared with the MRSA stains, and have been associated
with contamination of biomedical devices, which suggests an
ability to produce biofilms and therefore a tendency toward
resistance to QACs.23,24 QACs are commonly used in skin
disinfectant products, and, because GISA and hGISA strains
show the same propensity for resistance as do MRSA strains,
care should be taken whenever these compounds are used
for effective skin disinfection.
Triclosan susceptibility was also reduced for MRSA, GISA,
and hGISA, compared with MSSA, with MIC90 values of 2
mg/L and with some isolates having triclosan MICs of 2 and
4 mg/L. These data support previous reports of triclosan-
resistant strains of S. aureus, with triclosan MICs of 2–4 mg/
L and of 32 mg/L.25,26 Triclosan-containing preparations, such
as Aquasept, are regularly used in baths at concentrations of
4–5 mg/L to eradicate MRSA from carrier patients. However,
in the case of resistant isolates having triclosan MICs of 32
mg/L, and also those with low-level resistance (ie, 4 mg/L),
the triclosan concentration in the bath water would not be
sufficient to eradicate the microbe.26 In our study, no epi-
demic strains of type 16 MRSA exhibited elevated triclosan
MICs, as found in previous reports and in contrast to a report
in 2002 that showed triclosan resistance occurring in epidemic
strains of type 16 MRSA.27,28 The reduced levels of suscep-
tibility to the chlorhexidine-containing agents Hibisol and
Hibiscrub found for MRSA, GISA, and hGISA, compared
with those found for MSSA, confirm the association between
methicillin resistance and chlorhexidine resistance.1,21
Biocide concentrations used for disinfection and hand ster-
ilization are often varied, with initial applications usually be-
ing above MICs. However, these concentrations are lowered
by the process of dilution and/or by the duration of time
spent hand washing. For example, in the process of hand
washing, the concentration of the disinfectant is diluted by
the amount of water used. However, the lack of correlation
between biocide MICs and their lethal effects has been re-
ported previously.25,29,30 By the use of the mean log reduction
factor and percentage kill at the time tested for hand washing
(30 seconds), the effectiveness of these agents was assessed
for MSSA and MRSA and for hGISA and GISA (Table 4).
The average duration of hand washing in a healthcare setting
varied from 4.7 to 24 seconds, with the recommendation (by
the Healthcare Infection Control Practices Advisory Com-
mittee) in the United States being 15 seconds. The data ob-
tained allowed us to determine whether the intermediate van-
comycin resistance phenotype, with its altered physiological
features, had any affect on bacterial viability after hand wash-
ing (of less than 5-minute exposure).
By using this type of analysis, we showed that all Betadine
products containing 4%–10% povidone-iodine had a higher
log reduction factor for hGISA and GISA strains than for
MSSA and MRSA strains, which suggests that the hGISA and
GISA strains were more susceptible to these agents (Table 4).
The chlorhexidine-containing agents, Hibisol and Hibiscrub,
were very effective against all strains at 30 seconds, irrespec-
tive of vancomycin susceptibility phenotype. Hibisol was
slightly more effective, probably due to the additive effect of
the isopropanol base. After 30 seconds of exposure to Aqua-
sept (containing triclosan), and according to the EN 1040
standard criteria, the hGISA and GISA strains showed a lower
log reduction factor than did the MSSA and MRSA strains
(ie, 3.19 vs 3.95); therefore, Aquasept is less effective against
the hGISA and GISA strains than against the MSSA and
MRSA strains at 30 seconds (Figure). However, no difference
was found between strains exposed to Manusept. This could
be due to the additive effect of the isopropanol base, as seen
for Hibisol, compared with Hibiscrub. When related hGISA
and GISA strains were present, the efficacy of Aquasept, Man-
usept, and Sterillium were compared (Figure), and the data
clearly show a reduction in susceptibility to these agents with
increasing glycopeptide resistance. In the case of hexachlo-
rophene, the hGISA and GISA strains were more susceptible
than the MSSA and MRSA strains at 30 seconds, despite the
agent being less effective against the former strain types after
600 seconds of exposure.
In summary, infection control to prevent the spread of
MRSA infection in hospitals has focused on effective hand
disinfection. Although most hand disinfectants remain active
irrespective of the glycopeptide resistance phenotype, from
the result of our study, it seems that GISA and hGISA strains
are less susceptible to triclosan. On the other hand, Betadine
agents were more effective against GISA and hGISA strains,
especially after 30 seconds of exposure. Whether it is likely
that the altered physiology of hGISA and GISA strains, com-
pared with the vancomycin-susceptible MRSA and MSSA
strains, accounts for the differences in the effectiveness of
disinfection agents seen in our study is difficult to say. It is
therefore important to investigate the exact genetic alterations
taking place in these strains, so as to provide information for
the purpose of combating disease and the spread of disease
caused by these organisms that are resistant to certain clean-
ing agents.
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